http://ift.tt/eA8V8J
TEL AVIV, Israel, March 23, 2017 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, announced today that it has acquired Agalimmune Ltd., a private UK-based company with an innovative, anti-cancer...
March 23, 2017 at 04:23PM
http://ift.tt/2mXJqBh
from
http://ift.tt/2mXJqBh
No comments:
Post a Comment